BCLS Acquisition Corp.
(Note: This is a SPAC or blank-check IPO of 12.5 million Class A ordinary shares – NOT units.)
We intend to focus on industries that complement our management team’s background and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, we will pursue investments, primarily based in North America and Europe and selectively in other geographies, including Asia and emerging markets, in biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies.
Our sponsor, BCLS Acquisition Holdings, LP, is an affiliate of Bain Capital Life Sciences.
|Address||200 Clarendon Street Boston, Massachusetts 02116|
|Phone Number||(617) 516-2000|
|View Prospectus:||BCLS Acquisition Corp.|
|Revenues||$0 mil (last 12 months)|
|Net Income||$0 mil (last 12 months)|
|Price range||$10.00 - $10.00|
|Est. $ Volume||$125.0 mil|
|Manager / Joint Managers||Goldman Sachs/ Jefferies|
|Expected To Trade:||10/22/2020|
|Quiet Period Expiration Date:||Available only to Subscribers|
|Lock-Up Period Expiration Date:||Available only to Subscribers|
|SCOOP Rating||Available only to Subscribers|
|Rating Change||Available only to Subscribers|